Israeli Hospital Develops Blood Cancer Treatment With a 90% Success Rate
Using genetic-engineering technology, Israel's Hadassah University Medical Center has developed a successful way to treat a deadly blood cancer. They've recently announced a 90% success rate in treating patients with multiple myeloma cancer. This is an incredible achievement, given that multiple myeloma is considered an incurable cancer. The experimental treatment was developed over the past few years at the Jerusalem hospital's bone-marrow transplant and immunotherapy department. It involves using Chimeric Antigen Receptor T-Cell Therapy (CAR-T).